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Sgroups, waist-hip ratio, creatinine levels were signiﬁcantly high; glomerular ﬁltration
rate (GFR) was low in IGT or DM group compared to the other one whose OGTT test
was normal. In these parameters, GFR predicted IGT or DM with %72 sensitivity and
%55 speciﬁty. Before the test, patients with FPG <100 mg/dl, %30 of patients had
insülin resistance.
Conclusıon: In signiﬁcant part of patients with CAD, IGT or DM was present despite
normal FPG. Conventional risk factors, severity or duration of CAD cannot predict
IGT or DM. OGTT testing for IGT or DM, independent from FPG, would contribute
to the diagnosis.PP-334
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Aım: Vitamin D deﬁciency is common and may contribute to cardiovascular diseases.
We hypothesized that serum vitamin D (25OHD) levels would be inversely associated
with inﬂammation and with diastolic dysfunction. We therefore investigated the link
between serum vitamin D levels (i) echocardiographic measures and (ii) inﬂammatory
parameters.C214 JACC VoMaterıals-Methods: The cross-sectional study included 281 patients who were
referred to coronary angiography for stable angina pectoris. Patients were recruited
between December 2010 and November 2011. Patients with established congestive
heart failure, gout, chronic kidney disease (estimated glomeruler ﬁltration rate <60
ml/min/1.73 m2), acute infection were not included. We measured serum 25OHD
levels, C-reactive protein (CRP) and ﬁbrinogen levels. A radioimmunoassay proce-
dure was used to measure 25OHD (DiaSorin, Stillwater, MN). We also performed
standardized left ventricular (LV) echocardiograms and echocardiographic data were
used for classiﬁcation of systolic and diastolic dysfunction. We analyzed the relation
between serum levels of 25OHD and inﬂammatory markers and echocardiographic
measures of left ventricular mass and diastolic dysfunction.
Results: At baseline, subjects had a mean age of 59.510 years and 43.4% were
women. Left ventricular mass index, left atrial diamater, isovolumic relaxation time,
E/E’ ratio were signiﬁcantly higher in patients with lower 25OHD levels. In ordinal
logistic regression analysis higher 25OHD was negatively associated only with left
ventricular mass index, OR¼0.965 (0.939-0.992) p¼0.015, isovolumic relaxation
time, OR¼0.962 (0.939-0,985) p¼0.001, E/E’ ratio, OR¼0.874 (0.811-0.942)
p¼0.008 and CRP, OR¼0.802 (0.668-0.962) p¼0.021.
Conclusıon: Serum levels of 25OHD are signiﬁcantly associated with LV diastolic
dysfunction and left ventricular mass index although the effect size is rather small.
Longitudinal studies in larger populations are needed to establish ﬁrmly or refute
a causal relationship between vitamin D levels and diastolic dysfunction and left
ventricular mass index.
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Introductıon: Vitronectin (VN), a 459 aminoacid long glycoprotein with a mass of 75
kDa, is found in plasma, extracellular matrix and a granules of platelets. Plasma VN
levels were found to be elevated in patients with coronary artery disease (CAD), and
a positive correlation between VN levels and CAD severity has been demonstrated.
VN was also shown to be an independent predictor of adverse cardiovascular
outcomes following acute stenting in patients with acute myocardial infarction (AMI)
or stable angına.
The aim of this study was to assess prognostic signiﬁcance of serum VN levels at
admission in patients with ACS.
Method: Sixty-two patients (40 men, mean age 59.910.3 years and 22 women,
mean age 68.911.2 years), who had been admitted to coronary care unit with ﬁrst
time diagnosis of ACS (ST elevation myocardial infarction [STEMI], non-ST elevation
myocardial infarction [NSTEMI]) were consecutively included in the study.The control
group consisted of 18 stable patients in whom normal coronary arteries were docu-
mented in coronary angiography. Patients were divided into two sub-groups as STEMI
andNSTEMI and theywere followed up for sixmonths formajor adverse cardiovascular
events (MACE) consisting of cardiovascular mortality, re-infarction, hospitalization for
decompensated heart failure and life threatening arrhythmias. Blood samples were
drawn within 6 hours after onset of chest pain and serum VN, high sensitive C-reactive
protein (hs-CRP) and N-terminal probrain natriuretic peptide (NT-proBNP) levels were
measured using an enzyme immunoassay method. Also, TIMI and GRACE clinical risk
scores were calculated on admission for all ACS patients.
Results: The mean VN level in patients with MACE at six months was signiﬁcantly
higher (12.09 mg/ml +/- 20.79 mg/ml vs. 3.74 mg/ml +/- 7.48 mg/ml, p<0.001)
compared to the rest of the patient group. Patients in the upper two VN quartiles had
signiﬁcantly higher in-hospital (p¼0.026) and six months (p<0.001) MACE rates
compared to the patients in the lower two quartiles. Using ROC analysis, a cut-off VN
value of 2.16 mg/ml was able to predict MACE at six months with a positive predictive
value of 75%, and a negative predictive value of 76%, AUC: 0.76, %95 CI: 0.64-0.88
(p<0.001) (Figure). VN was also able to predict MACE independent of other prog-
nostic markers like age, hs-CRP, pro-BNP, TIMI, GRACE, and LVEF in multivariate
regression analysis (p¼0.001).
Conclusıon: VN levels on admission predict in-hospital and medium-term MACE in
patients with ACS independent of conventional risk predictors. VN may have a utility
as a prognostic marker in patients with ACS.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
P
O
S
T
E
R
SPP-336
The Relationship between Gamma Glutamyl Transferase Levels and the Clinical
Outcomes in Patients with ST-Segment Elevation Myocardial Infarction
Undergoing Primary PCI
Mehmet Gül1, Hüseyin Uyarel2, Mehmet Ergelen2, Ahmet Ekmekci3, Ender Özal1,
Ahmet Murat3, Seref Kul2, Omer Çelik1, Gürkan Karaca3, Faruk Akturk1,
Abdurrrahman Eksik1
1Istanbul Mehmet Akif Ersoy Thoracic - Cardiovascular Surgery Training and
Research Hospital Cardiology Department, Istanbul, 2Bezmialem Vakif University,
School of Medicine, Cardiology Department, Istanbul, 3Siyami Ersek Cardiovascular
and Thoracic Surgery Center, Cardiology Department, Istanbul
Objectıves: Serum gamma glutamyl transferase (GGT) activity has been shown to be
related to the development of atherosclerosis and cardiovascular events. The aim of
this study was to evaluate the prognostic value of GGT in patients with ST-segment
elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary
intervention (PCI).
Methods: A total of 683 consecutive patients with STEMI who underwent primary
PCI were evaluated. The study population was divided into tertiles based on admission
GGT values. A high GGT (n¼221) was deﬁned as a value in the upper third tertile
(GGT >37), and a low GGT (n¼462) was deﬁned as any value in the lower two
tertiles (GGT 37). The mean follow-up time was 29 months.
Results: The in-hospital mortality rate was signiﬁcantly higher in patients in the high
GGT group (7.2% vs. 1.7%, p<0.001), as was the rate of adverse outcomes in patients
with high GGT levels. In multivariate analyses, a signiﬁcant association was noted
between high GGT levels and adjusted risk of in-hospital cardiovascular mortality
(odds ratio¼8.6, 95% conﬁdence interval (CI)¼2.3–32.4; p¼0.001). In a receiver
operating characteristic (ROC) curve analysis, a GGT value >37 was identiﬁed as an
effective cutoff point in STEMI for in-hospital cardiovascular mortality (area under
curve¼0.71, 95% CI: 0.59–0.82, p<0.001). There were no differences in long-term
adverse outcomes rates between the two groups.
Conclusıon: GGT is a readily available clinical laboratory value associated with in-
hospital adverse outcomes in patients with STEMI who undergo primary PCI.
However, there was no association with long-term mortality.
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Aım: A bundle of myocardium that bridges over the epicardial coronary artery is
called as Myocardial Bridging (MB). It is supposed to restrict the coronary ﬂow
anatomically and functionally when myocardial oxygen demand increased due to
strenuous exercise. While ST/T changes on ECG during exercise may represent
abnormality of coronary ﬂow and also ischemia upon exertion, ST/T changes on rest
ECG may represent silent ischemia due to coronary pathology. However abnormalities
of myocardium such as local myocardial thickening, isolated papillary muscle
hypertrophy, etc. may cause ST/T changes on resting ECG. We aimed to evaluate and
discuss whether it could be associated with variable ST and T wave changes on resting
ECG and to discuss its anatomically signiﬁcance.
Materıal-Method: We retrospectively evaluated the changes on resting ECG in 36
patients with MB diagnosed with MSCT angiography.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTResults: Of the 36 subjects; 16 had ST and T wave changes, 17 had only ST changes.
Downsloping and horizontal ST despression was observed in 16 and 17 patients,
respectively. 25 had <0.5 mm ST depression and 8 had <1 mm ST depression.
Flattening or inversion of T wave was observed in 16 and 16 subjects, respectively.
ECG changes were localized on inferior, lateral and inferior-lateral derivations in 15, 3
and 17 patients with MB.
Conclusıon: Various types of ECG changes may accompany with the presence of MB
in patients with. <0.5 mm depression of ST segment and ﬂattening/inversion of T
wave are the predominant changes. Downsloping depression of ST segment accom-
panied with not deeply but minimally inverted T wave inversion may remind the ECG
changes which may be observed in local myocardial diseases clinically represented
with myocardial wall thickening or myocardial disarray such as e.g. isolated papillary
hypertrophy. Thus those ECG changes observed on the resting ECG in patients with
MB may represent not only a silent ischemia but also a histological or regional
abnormality of myocardium consisting bridging segment. Further studies in order to
evaluate that regional abnormality of myocardial tissue by means of cardiac magnetic
resonance imaging may be designed in the future.ERS C215
